4 Insights on decentralized trials for biotechs
The COVID-19 pandemic accelerated the adoption of decentralized clinical trials (DCTs) by biopharma companies. The clinician-patient relationship will always be key to clinical trials, but decentralized aspects such as direct-to-patient shipments and telehealth are here to stay. Here are four things we have learned about DCTs that biotech companies can consider when designing a decentralized or hybrid trial.
Related Insights
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Including patients in DCT design
Sep 13, 2022
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Podcast
Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment
May 9, 2022
Blog
End-to-end risk management: Getting the most from your program
Apr 4, 2022
Video
How to transition existing trials under EU-CTR
Feb 1, 2023
Related Insights
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Including patients in DCT design
Sep 13, 2022
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Podcast
Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment
May 9, 2022
Blog
End-to-end risk management: Getting the most from your program
Apr 4, 2022
Video
How to transition existing trials under EU-CTR
Feb 1, 2023